📰 Thomas Voets News
Thomas Voets News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Voets. Real-time updates on events, politics, business and more.
January 11, 2022
Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), along with CD3 and LICR at KU Leuven, announced today that they have entered into an exclusive global license and research agreement to develop and commercialize first-in-class TRPM3 antagonists to address the growing proportion of people worldwide living with chronic pain disorders.
January 10, 2022
/PRNewswire/ -- Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), along with CD3 and LICR at KU Leuven,...
January 10, 2022
/PRNewswire/ -- Biohaven Therapeutics Ltd., a subsidiary of Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), along with CD3 and LICR at KU Leuven,...
January 10, 2022
GuruFocus Article or News written by PRNewswire and the topic is about:
January 10, 2022
Biohaven Enters Exclusive License and Research Collaboration Agreement with KU Leuven to Advance First-in-Class TRPM3 Antagonists for the Treatment of Pain - read this article along with other careers information, tips and advice on BioSpace
September 17, 2021
In heel wat keukens wordt er kwistig met pepers, chili en ander heet spul gekookt. Niet iedereen is fan, maar het is vaak een bron van een bizar soort trots, pikant kunnen eten. En zelfs bij ons staan tegenwoordig hotsauzen op tafel. Waarom eigenlijk?